Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.
2.

HIV-1 integrase: the next target for AIDS therapy?

d'Angelo J, Mouscadet JF, Desmaële D, Zouhiri F, Leh H.

Pathol Biol (Paris). 2001 Apr;49(3):237-46. Review.

PMID:
11367559
3.

Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.

Tarrago-Litvak L, Andreola ML, Fournier M, Nevinsky GA, Parissi V, de Soultrait VR, Litvak S.

Curr Pharm Des. 2002;8(8):595-614. Review.

PMID:
11945161
4.

The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.

Witvrouw M, Debyser Z.

Verh K Acad Geneeskd Belg. 2003;65(5):325-34. Review.

PMID:
14671848
5.

Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.

Luo ZG, Tan JJ, Zeng Y, Wang CX, Hu LM.

Mini Rev Med Chem. 2010 Oct;10(11):1046-57. Review.

PMID:
21044030
6.

Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.

Maurin C, Bailly F, Cotelle P.

Curr Med Chem. 2003 Sep;10(18):1795-810. Review.

PMID:
12871105
7.

HIV type 1 integrase inhibitors: from basic research to clinical implications.

Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.

AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.

PMID:
18820719
8.

New developments in diketo-containing inhibitors of HIV-1 integrase.

Zhao G, Wang C, Liu C, Lou H.

Mini Rev Med Chem. 2007 Jul;7(7):707-25. Review.

PMID:
17627583
9.

Targeting HIV-1 integrase with strand transfer inhibitors.

Li Y, Xuan S, Feng Y, Yan A.

Drug Discov Today. 2015 Apr;20(4):435-49. doi: 10.1016/j.drudis.2014.12.001. Epub 2014 Dec 6. Review.

PMID:
25486307
10.

HIV-1 integrase and RNase H activities as therapeutic targets.

Andréola ML, De Soultrait VR, Fournier M, Parissi V, Desjobert C, Litvak S.

Expert Opin Ther Targets. 2002 Aug;6(4):433-46. Review.

PMID:
12223059
11.

Novel inhibitors of HIV-1 integration.

Witvrouw M, Van Maele B, Vercammen J, Hantson A, Engelborghs Y, De Clercq E, Pannecouque C, Debyser Z.

Curr Drug Metab. 2004 Aug;5(4):291-304. Review.

PMID:
15320701
12.

HIV-1 integrase: a target for new AIDS chemotherapeutics.

Anthony NJ.

Curr Top Med Chem. 2004;4(9):979-90. Review.

PMID:
15134552
13.

Molecular mechanisms of HIV integration and therapeutic intervention.

Vandegraaff N, Engelman A.

Expert Rev Mol Med. 2007 Feb 26;9(6):1-19. Review.

PMID:
17320002
14.

[How proviral DNA is integrated into the host cell DNA and how this process can be inhibited].

Mirambeau G.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:11-6. Review. Spanish.

PMID:
19572420
15.

HIV-1 integration as a target for antiretroviral therapy: a review.

Pluymers W, De Clercq E, Debyser Z.

Curr Drug Targets Infect Disord. 2001 Aug;1(2):133-49. Review.

PMID:
12455410
16.

The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.

Christ F, Debyser Z.

Virology. 2013 Jan 5;435(1):102-9. doi: 10.1016/j.virol.2012.09.033. Review. Erratum in: Virology. 2013 Mar 30;438(1):50.

17.

HIV integrase as a target for antiviral chemotherapy.

Nair V.

Rev Med Virol. 2002 May-Jun;12(3):179-93. Review.

PMID:
11987143
18.
19.

The hunt for HIV-1 integrase inhibitors.

Lataillade M, Kozal MJ.

AIDS Patient Care STDS. 2006 Jul;20(7):489-501. Review.

PMID:
16839248
20.

Development of integrase inhibitors for treatment of AIDS: an overview.

Dubey S, Satyanarayana YD, Lavania H.

Eur J Med Chem. 2007 Sep;42(9):1159-68. Epub 2007 Jan 30. Review.

PMID:
17367896

Supplemental Content

Support Center